Gyeonggi-do, South Korea

Han A Kang

This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Caregen Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Han A Kang. Retrieved from https://idiyas.com/inventor/han-a-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Han A Kang

Introduction: Han A Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in developing solutions to combat cell damage caused by environmental factors.

Latest Patents: Han A Kang holds a patent for a peptide that exhibits protective activity against cell damage caused by particulate matter. This innovative peptide has potential applications in various fields, including medicine and environmental health. The patent emphasizes the importance of this peptide in safeguarding cellular integrity in adverse conditions.

Career Highlights: Han A Kang is currently associated with Caregen Co., Ltd., a company known for its advancements in biotechnology and regenerative medicine. His work at Caregen has allowed him to focus on developing innovative solutions that address critical health issues.

Collaborations: Han A Kang has collaborated with esteemed colleagues, including Yong Ji Chung and Eun Mi Kim. Their combined expertise has contributed to the successful development of groundbreaking technologies in their field.

Conclusion: Han A Kang's contributions to biotechnology, particularly through his patented peptide, highlight his role as an innovative inventor. His work continues to pave the way for advancements that can significantly impact health and environmental safety.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…